PAG
DGX icon

Private Advisor Group’s Quest Diagnostics DGX Stock Holding History

Private Advisor Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Sell
5,415
-162
-3% -$31.5K 0.01% 1372
2025
Q4 		$968K Sell
5,577
-3
-0.1% -$546 ﹤0.01% 1425
2025
Q3 		$1.06M Sell
5,580
-721
-11% -$128K 0.01% 1334
2025
Q2 		$1.13M Buy
6,301
+330
+6% +$57.3K 0.01% 1246
2025
Q1 		$1.01M Sell
5,971
-378
-6% -$62.1K 0.01% 1238
2024
Q4 		$958K Sell
6,349
-1,188
-16% -$185K 0.01% 1247
2024
Q3 		$1.17M Buy
7,537
+1,444
+24% +$216K 0.01% 1161
2024
Q2 		$834K Buy
6,093
+289
+5% +$39.6K 0.01% 1286
2024
Q1 		$773K Sell
5,804
-197
-3% -$25.6K 0.01% 1283
2023
Q4 		$827K Buy
6,001
+1,662
+38% +$219K 0.01% 1212
2023
Q3 		$529K Buy
4,339
+27
+0.6% +$3.6K ﹤0.01% 1350
2023
Q2 		$606K Sell
4,312
-3,413
-44% -$471K 0.01% 1284
2023
Q1 		$1.09M Buy
7,725
+88
+1% +$12.6K 0.01% 951
2022
Q4 		$340K Buy
7,637
+2,350
+44% +$338K 0.02% 706
2022
Q3 		$649K Sell
5,287
-3,956
-43% -$521K 0.01% 1115
2022
Q2 		$1.23M Buy
9,243
+2,670
+41% +$364K 0.01% 978
2022
Q1 		$899K Sell
6,573
-590
-8% -$82.2K 0.01% 1140
2021
Q4 		$1.24M Sell
7,163
-2,129
-23% -$324K 0.01% 1012
2021
Q3 		$1.35M Buy
9,292
+1,356
+17% +$198K 0.01% 1060
2021
Q2 		$1.05M Buy
7,936
+863
+12% +$113K 0.01% 1043
2021
Q1 		$908K Buy
7,073
+1,370
+24% +$169K 0.01% 1040
2020
Q4 		$680K Buy
5,703
+7
+0.1% +$853 0.01% 1066
2020
Q3 		$652K Sell
5,696
-2,192
-28% -$259K 0.01% 958
2020
Q2 		$899K Buy
7,888
+2,646
+50% +$281K 0.01% 800
2020
Q1 		$421K Sell
5,242
-600
-10% -$62.1K 0.01% 950
2019
Q4 		$624K Sell
5,842
-593
-9% -$61.8K 0.01% 953
2019
Q3 		$689K Sell
6,435
-770
-11% -$79K 0.01% 940
2019
Q2 		$734K Sell
7,205
-2,500
-26% -$240K 0.01% 870
2019
Q1 		$873K Buy
9,705
+3,789
+64% +$328K 0.02% 730
2018
Q4 		$494K Sell
5,916
-900
-13% -$84.4K 0.01% 844
2018
Q3 		$736K Buy
6,816
+2,951
+76% +$324K 0.02% 817
2018
Q2 		$426K Sell
3,865
-363
-9% -$37.8K 0.01% 820
2018
Q1 		$424K Sell
4,228
-235
-5% -$24.1K 0.02% 731
2017
Q4 		$445K Sell
4,463
-1,855
-29% -$176K 0.02% 714
2017
Q3 		$576K Sell
6,318
-1,616
-20% -$172K 0.01% 836
2017
Q2 		$862K Buy
7,934
+416
+6% +$44K 0.02% 589
2017
Q1 		$736K Buy
7,518
+1,296
+21% +$124K 0.02% 648
2016
Q4 		$580K Buy
6,222
+183
+3% +$15.8K 0.02% 685
2016
Q3 		$506K Sell
6,039
-432
-7% -$36.3K 0.02% 648
2016
Q2 		$525K Buy
6,471
+1,727
+36% +$132K 0.02% 613
2016
Q1 		$338K Sell
4,744
-3,508
-43% -$235K 0.02% 721
2015
Q4 		$587K Buy
8,252
+1,961
+31% +$132K 0.03% 541
2015
Q3 		$387K Sell
6,291
-5,541
-47% -$387K 0.02% 653
2015
Q2 		$858K Buy
11,832
+6,130
+108% +$453K 0.04% 424
2015
Q1 		$438K Buy
5,702
+2,085
+58% +$149K 0.03% 605
2014
Q4 		$243K Buy
+3,617
New +$228K 0.02% 796

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Private Advisor Group's DGX Position: Q1 2026 in Review

Private Advisor Group reduced its Quest Diagnostics (DGX) stake by 2.9% in Q1 2026, selling an estimated $31.5K and leaving 5,415 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #1372.

Private Advisor Group first reported a position in DGX in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.35M in Q3 2021. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Private Advisor Group held 5,415 shares of Quest Diagnostics worth $1.06M as of Q1 2026.
  • Private Advisor Group sold 162 Quest Diagnostics shares in Q1 2026, an estimated $31.5K.
  • Quest Diagnostics made up 0.01% of Private Advisor Group's portfolio in Q1 2026, its #1372 holding.
  • Private Advisor Group first reported a position in Quest Diagnostics in Q4 2014 and has held it in 46 quarters since.
  • Private Advisor Group's Quest Diagnostics position peaked at $1.35M in Q3 2021.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.